WAYNE, PA — Palvella Therapeutics Inc. (Nasdaq: PVLA) announced the launch of “BEYOND mLM,” a disease awareness campaign and ...

BEYONDmLM.comcampaign designed to educate, engage, and empower patients, caregivers, and healthcare professionalsCampaign developed and launched ...

Patent strengthens global intellectual property protection for QTORIN™ rapamycin, Palvella’s lead product candidate from the QTORIN™ platform, in ...

Orbital venous-lymphatic malformations are congenital vascular malformations that infiltrate into adjacent tissues comprising of arterial, venous, and lymphatic elements. These elements have led to ...

Our bodies are made up of 60,000 miles of complex pipes that play a vital role in transporting nutrients throughout our bodies, performing waste disposal, and supplying our organs with fresh oxygen ...

Palvella Therapeutics, a clinical-stage biopharmaceutical company, announced the acceptance of an abstract for a poster presentation at the Society for Investigative Dermatology Annual Meeting on the ...

Lymphatic malformation (LM), a vascular anomaly originating from lymphatic endothelial cells, can progress to malignant lymphangiosarcoma (LAS) in a fraction of patients. Scientists from the ...

PALO ALTO, Calif., Feb. 02, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) and affiliate Venthera, which is focused on developing new treatment options for patients with rare vascular ...

Kennedy Hubbard looks different than most 20-somethings. “We’re well aware of how she appears,” Kennedy’s mom, Leanne, said. “It’s human nature to stare. It’s just not something you see all the time.

BEYONDmLM.com campaign designed to educate, engage, and empower patients, caregivers, and healthcare professionals Campaign developed and launched in close collaboration with leading nonprofit ...